Rocket One Inc. Common Stock (NASDAQ:RKTO) Downgraded by Wall Street Zen to Strong Sell

Wall Street Zen lowered shares of Rocket One Inc. Common Stock (NASDAQ:RKTO) from a sell rating to a strong sell rating in a report issued on Saturday morning.

Several other research firms also recently weighed in on RKTO. D. Boral Capital reissued a “buy” rating and set a $5.00 price target on shares of Rocket One Inc. Common Stock in a research report on Wednesday, March 25th. Weiss Ratings upgraded Rocket One Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, June 23rd. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $5.00.

Rocket One Inc. Common Stock Price Performance

Shares of RKTO opened at $0.81 on Friday. The firm has a 50 day simple moving average of $1.04 and a 200-day simple moving average of $0.95. Rocket One Inc. Common Stock has a 1-year low of $0.49 and a 1-year high of $2.45. The stock has a market cap of $18.11 million, a price-to-earnings ratio of -1.01 and a beta of 0.93.

Rocket One Inc. Common Stock (NASDAQ:RKTO) last issued its quarterly earnings data on Friday, May 15th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.03).

Institutional Trading of Rocket One Inc. Common Stock

A number of hedge funds have recently bought and sold shares of RKTO. DRW Securities LLC purchased a new stake in Rocket One Inc. Common Stock in the 4th quarter worth approximately $257,000. Citadel Advisors LLC purchased a new position in shares of Rocket One Inc. Common Stock during the 3rd quarter worth $232,000. Virtu Financial LLC purchased a new position in shares of Rocket One Inc. Common Stock during the 3rd quarter worth $184,000. Kestra Private Wealth Services LLC purchased a new position in shares of Rocket One Inc. Common Stock during the 3rd quarter worth $51,000. Finally, Geode Capital Management LLC boosted its holdings in shares of Rocket One Inc. Common Stock by 18.0% during the fourth quarter. Geode Capital Management LLC now owns 181,112 shares of the company’s stock worth $179,000 after purchasing an additional 27,577 shares during the last quarter. Institutional investors and hedge funds own 7.08% of the company’s stock.

About Rocket One Inc. Common Stock

Hoth Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure.

Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis.